Trials / Unknown
UnknownNCT02943356
Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction
Observational Study to Evaluate the Effect of Tadalafil 5mg Once Daily on Erectile Dysfunction and QOL in Andropause Patients With Erectile Dysfunction
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- The Catholic University of Korea · Academic / Other
- Sex
- Male
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
Observational study to evaluate the effect of Tadalafil 5mg once daily on Erectile Dysfunction and QOL in Andropause patients with Erectile Dysfunction. Patients will be observed for 8weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tadalafil | Patients will be treated with Tadalafil for 8 weeks |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2016-10-24
- Last updated
- 2016-10-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02943356. Inclusion in this directory is not an endorsement.